About this episode
GSK近日公布，其在研反义寡核苷酸药物bepirovirsen治疗慢性乙型肝炎的两项关键3期临床试验取得突破性阳性结果。数据同步发表于《新英格兰医学杂志》，并在欧洲肝脏研究学会年会上公布，有望改写全球慢乙肝治疗格局。
Get every episode summarized
Each time 天方烨谈 publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
